Revolutionize Drug Development with AI/ML

Poor solubility remains one of the most significant challenges in drug development, affecting over 70% of molecules and hindering their path to clinical trials. The traditional trial-and-error methods to resolve solubility and bioavailability issues are costly and time-consuming. Now, artificial intelligence (AI) and machine learning (ML) are transforming this process, offering predictive solutions to optimize drug development.